desethylamiodarone has been researched along with Disease Models, Animal in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brocks, DR; El-Kadi, AO; Korashy, H; Patel, JP; Shayeganpour, A | 1 |
Bolderman, RW; Bruin, P; de Jong, MM; Dias, AA; Hermans, JJ; Maessen, JG; Rademakers, LM; van der Veen, FH | 1 |
Bognar, Z; Gallyas, F; Sumegi, B; Tapodi, A; Toth, A; Varbiro, G; Veres, B | 1 |
Brien, JF; Evans, CD; Leeder, RG; Massey, TE | 1 |
Blake, TL; Reasor, MJ | 1 |
Chen, BP; Chow, MS; Fan, C; Kluger, J; White, CM; Zhou, L | 1 |
Brien, JF; Daniels, JM; Massey, TE | 1 |
7 other study(ies) available for desethylamiodarone and Disease Models, Animal
Article | Year |
---|---|
The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cytochrome P-450 Enzyme System; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hyperlipidemias; Injections, Intravenous; Male; Microsomes, Liver; Poloxamer; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2008 |
Epicardial application of an amiodarone-releasing hydrogel to suppress atrial tachyarrhythmias.
Topics: Administration, Cutaneous; Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease Models, Animal; Drug Delivery Systems; Electrodes, Implanted; Goats; Heart Atria; Hydrogel, Polyethylene Glycol Dimethacrylate; Pericardium; Polyethylene Glycols; Refractory Period, Electrophysiological; Tachycardia, Ectopic Atrial | 2011 |
Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition.
Topics: Amiodarone; Animals; Apoptosis Inducing Factor; Biological Transport; Disease Models, Animal; Energy Metabolism; Flavoproteins; Membrane Proteins; Mitochondria; Myocardial Ischemia; Oxygen Consumption; Permeability; Protective Agents; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2003 |
Resistance of the hamster to amiodarone-induced pulmonary toxicity following repeated intraperitoneal administration.
Topics: Amiodarone; Animals; Chromatography, High Pressure Liquid; Cricetinae; Disease Models, Animal; Hydroxyproline; Injections, Intraperitoneal; Liver; Lung; Male; Mesocricetus; Organ Size; Pulmonary Fibrosis; Tissue Distribution | 1994 |
Metabolism of amiodarone following intratracheal instillation in hamsters.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cricetinae; Disease Models, Animal; Intubation, Intratracheal; Kinetics; Liver; Lung; Male; Mesocricetus; Microsomes; Pulmonary Fibrosis; Umbelliferones | 1995 |
A comparison of the antifibrillatory effects of desethylamiodarone to amiodarone in a swine model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophysiology; Injections, Intravenous; Swine; Ventricular Fibrillation | 1999 |
Pulmonary fibrosis induced in the hamster by amiodarone and desethylamiodarone.
Topics: Amiodarone; Animals; Chromatography, High Pressure Liquid; Cricetinae; Disease Models, Animal; Histocytochemistry; Hydroxyproline; Lung; Male; Mesocricetus; Pulmonary Fibrosis; Tissue Distribution | 1989 |